📰 Project Bioshield News

Page 2 - Project Bioshield News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Project Bioshield. Real-time updates on events, politics, business and more.

Soligenix Announces Pricing of $4.75 Million Public Offering

April 18, 2024

PRINCETON, N.J., April 18, 2024 /PRNewswire/ -- Soligenix, Inc. , a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an...

New York United States National Institute Of Allergy Us Congress Exchange Commission Defense Threat Reduction Agency

Source: marketscreener.com

FDA Grants Soligenix Orphan Drug Designation for the Prevention and Post-Exposure Prophylaxis Against Sudan Ebolavirus Infection

April 11, 2024

/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing...

United States Axel Lehrer Oreola Donini Our Public Health Solutions Us Congress Exchange Commission

Source: prnewswire.com

Soligenix Announces Agreement on the Design of a Second Confirmatory Placebo-Controlled Trial for HyBryte™ With the European Medicines Agency

April 3, 2024

/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing...

United States Biomedical Advanced Research Exchange Commission Us Congress Prnewswire Soligenix Inc European Medicines Agency

Source: prnewswire.com

Spectral AI, Inc. (NASDAQ:MDAI) Q4 2023 Earnings Call Transcript

April 1, 2024

Operator: Good afternoon, and welcome to the Spectral AI Fourth Quarter and Full Year 2023 Financial Results Conference Call. [Operator Instructions].

United States United Kingdom John Vandermosten Vince Capone Ryan Zimmerman Pete Carlson

Source: insidermonkey.com

Spectral AI, Inc. (NASDAQ:MDAI) Q4 2023 Earnings Call Transcript

April 1, 2024

Operator: Good afternoon, and welcome to the Spectral AI Fourth Quarter and Full Year 2023 Financial Results Conference Call. [Operator Instructions].

United States United Kingdom Ryan Zimmerman Vince Capone Vincent Capone Peter Carlson

Source: insidermonkey.com

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Soligenix Announces Formation of Behçet's Disease Medical Advisory Board

February 8, 2024

/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing...

Hospital For Special Surgery New York United States New York University Beaumont Hospital United Kingdom

Source: prnewswire.com

Soligenix to Present at The Microcap Conference

January 25, 2024

/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing...

Development Authority Exchange Commission Us Development Us Congress National Institute Of Allergy Defense Threat Reduction Agency

Source: prnewswire.com

FDA Grants Soligenix "Fast Track" Designation for Dusquetide in the Treatment of Oral Lesions of Behçet's Disease

January 8, 2024

PRINCETON, N.J., Jan. 8, 2024 /PRNewswire/ -- Soligenix, Inc. , a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an...

United Kingdom Robert Hancock Christopherj Schaber B Brett Finlay Biomedical Advanced Research University Of British Columbia

Source: marketscreener.com

Soligenix Announces Top-line Results of the Phase 2a Study of SGX302 (Synthetic Hypericin) in Patients with Mild-to-Moderate Psoriasis

January 4, 2024

Clinical Success Achieved in Second Cohort of Patients PRINCETON, N.J., Jan. 4, 2024 /PRNewswire/ -- Soligenix, Inc. , a late-stage biopharmaceutical company focused on developing and...

Richard Straube Christopherj Schaber Prnewswire Soligenix Inc Drug Administration World Health Organization Us Congress

Source: marketscreener.com

Soligenix Announces Publication Demonstrating Complete Protection Against Filovirus Disease in Nonhuman Primate Models of Ebola and Marburg Viruses

January 2, 2024

Single-vial thermostabilized bivalent vaccine demonstrates simultaneous protection against two lethal viruses PRINCETON, N.J., Jan. 2, 2024 /PRNewswire/ -- Soligenix, Inc. , a late-stage...

United States University Of Hawaii At Manoa Axel Lehrer Oreola Donini Prnewswire Soligenix Inc Department Of Tropical Medicine

Source: marketscreener.com

← Previous 1 2 3 4 Next →

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

Page 2 - Project Bioshield News Today

Stay Updated with Latest News

Explore More Categories